These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1330023

  • 1. Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.
    Ikenaka Y, Yajima K, Yahara H, Maruyama H, Matsumoto K, Okada K, Ueshima S, Matsuo O.
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):381-7. PubMed ID: 1330023
    [Abstract] [Full Text] [Related]

  • 2. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.
    Yahara H, Matsumoto K, Maruyama H, Nagaoka T, Ikenaka Y, Yajima K, Fukao H, Ueshima S, Matsuo O.
    Thromb Haemost; 1994 Dec; 72(6):893-9. PubMed ID: 7740460
    [Abstract] [Full Text] [Related]

  • 3. Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.
    de Vries C, Veerman H, Nesheim ME, Pannekoek H.
    Thromb Haemost; 1991 Mar 04; 65(3):280-5. PubMed ID: 1904654
    [Abstract] [Full Text] [Related]

  • 4. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G, Pascucci C, Nenci GG, Mele A, Bürgi R, Heim J.
    Thromb Haemost; 1993 Aug 02; 70(2):294-300. PubMed ID: 8236138
    [Abstract] [Full Text] [Related]

  • 5. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domain.
    Yahara H, Matsumoto K, Maruyama H, Nagaoka T, Ikenaka Y, Yajima K, Fukao H, Ueshima S, Matsuo O.
    Thromb Haemost; 1992 Dec 07; 68(6):672-7. PubMed ID: 1287881
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.
    Collen D, Lijnen HR, Bulens F, Vandamme AM, Tulinsky A, Nelles L.
    J Biol Chem; 1990 Jul 25; 265(21):12184-91. PubMed ID: 2115513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fibrin affinity and clearance of t-PA deletion and substitution analogues.
    Johannessen M, Diness V, Pingel K, Petersen LC, Rao D, Lioubin P, O'Hara P, Mulvihill E.
    Thromb Haemost; 1990 Feb 19; 63(1):54-9. PubMed ID: 2111048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH, Nieuwenbroek NM, Verheijen JH.
    Protein Eng; 1995 Dec 19; 8(12):1295-1302. PubMed ID: 8869642
    [Abstract] [Full Text] [Related]

  • 14. Construction, expression and the characterization of t-PA mutants with increased plasma half-life and resistance to inhibition by PAI-1.
    Liu S, Huang P, Huang C.
    Chin J Biotechnol; 1995 Dec 19; 11(1):17-25. PubMed ID: 7548767
    [Abstract] [Full Text] [Related]

  • 15. Construction, expression and characterization of tissue-type plasminogen activator mutants.
    Liu S, Huang P, Huang C.
    Sci China B; 1995 Nov 19; 38(11):1341-8. PubMed ID: 8745532
    [Abstract] [Full Text] [Related]

  • 16. Structure and function of human tissue-type plasminogen activator (t-PA).
    van Zonneveld AJ, Veerman H, MacDonald ME, van Mourik JA, Pannekoek H.
    J Cell Biochem; 1986 Nov 19; 32(3):169-78. PubMed ID: 3097031
    [Abstract] [Full Text] [Related]

  • 17. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
    Yang VC, Naik SS, Song H, Dombkowski AA, Crippen G, Liang JF.
    J Control Release; 2005 Dec 10; 110(1):164-76. PubMed ID: 16260060
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serpin-resistant mutants of human tissue-type plasminogen activator.
    Madison EL, Goldsmith EJ, Gerard RD, Gething MJ, Sambrook JF.
    Nature; 1989 Jun 29; 339(6227):721-4. PubMed ID: 2500599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.